Verastem (VSTM) Cash & Current Investments (2011 - 2026)

Verastem's (VSTM) quarterly Cash & Current Investments came in at $197.8 million in Q1 2026, up 68.26% year-on-year from $117.6 million in Q1 2025, and down 3.49% quarter-over-quarter from $205.0 million in Q4 2025.

Verastem (VSTM) Cash & Current Investments (2011 - 2026) Analysis & Trends

Verastem's Cash & Current Investments history runs 16 years deep, the most recent figure standing at $197.8 million for Q1 2026.

  • On a quarterly basis, Cash & Current Investments rose 68.26% year-over-year to $197.8 million in Q1 2026; TTM through Mar 2026 was $197.8 million, a 68.26% increase from a year earlier, with the FY2025 full-year figure at $205.0 million, up 130.8% from the prior year.
  • Cash & Current Investments declined to $197.8 million in Q1 2026 per VSTM's latest filing, from $205.0 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $205.0 million in Q4 2025 and bottomed at $83.4 million in Q2 2024.
  • The 5-year median for Cash & Current Investments is $113.2 million (2024), against an average of $130.1 million.
  • Across the five-year window, Cash & Current Investments slumped 54.46% in 2024 and jumped 130.8% in 2025, its largest moves.
  • Year by year, Cash & Current Investments stood at $92.0 million in 2022, then soared by 48.99% to $137.1 million in 2023, then plunged by 35.23% to $88.8 million in 2024, then soared by 130.8% to $205.0 million in 2025, then fell by 3.49% to $197.8 million in 2026.
  • Per Business Quant, the three latest VSTM Cash & Current Investments figures stand at $197.8 million (Q1 2026), $205.0 million (Q4 2025), and $137.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Oculis Holding AG 65,839.48 Bn 65,839.20 Bn - 283.54 Mn
2 Nanobiotix 1,912.79 Bn 1,912.72 Bn - 61.40 Mn
3 Akari Therapeutics 1,015.37 Bn 1,015.37 Bn - -
4 BeOne Medicines 471.39 Bn 466.59 Bn 1.35 Bn 4.79 Bn
5 Vertex Pharmaceuticals 122.52 Bn 115.28 Bn 2.59 Bn 7.25 Bn
6 Regeneron Pharmaceuticals 70.33 Bn 61.58 Bn 3.31 Bn 8.75 Bn
7 Belite Bio 62.74 Bn 62.74 Bn - -
8 Argenx Se 56.10 Bn 50.91 Bn 1.41 Bn 5.18 Bn
9 Alnylam Pharmaceuticals 37.52 Bn 34.51 Bn 959.66 Mn 3.01 Bn
10 Verastem 627.10 Mn 429.28 Mn 15.90 Mn 197.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 197.83 Mn
Dec 31, 2025 204.99 Mn
Sep 30, 2025 137.71 Mn
Jun 30, 2025 164.32 Mn
Mar 31, 2025 117.57 Mn
Dec 31, 2024 88.82 Mn
Sep 30, 2024 113.18 Mn
Jun 30, 2024 83.37 Mn
Mar 31, 2024 110.13 Mn
Dec 31, 2023 137.13 Mn
Sep 30, 2023 165.66 Mn
Jun 30, 2023 183.09 Mn
Mar 31, 2023 111.20 Mn
Dec 31, 2022 92.04 Mn
Sep 30, 2022 103.98 Mn
Jun 30, 2022 94.31 Mn
Mar 31, 2022 106.28 Mn
Dec 31, 2021 153.80 Mn
Sep 30, 2021 103.42 Mn
Jun 30, 2021 108.14 Mn